Health Care · Health Care Equipment
Idexx Laboratories: revenue, profit and cash flow
In fiscal 2025, Idexx Laboratories had revenue of $4.3B, up 10.4% a year on average since 2015, and net income of $1.06B (24.6% of revenue). It has 13% fewer shares than in 2015.
Revenue, fiscal 2025
average annual revenue growth since 2015 · +10.4% vs 2024
- Ticker
- IDXX · Nasdaq
- Sector
- Health Care
- Sub-industry
- Health Care Equipment
- Headquarters
- Westbrook, Maine
- Founded
- 1983
- In the S&P 500 since
- January 5, 2017
- Latest fiscal year
- 2025, ended December 31, 2025
- SEC filer
- Idexx Laboratories Inc /De · CIK 0000874716
Revenue and net income
Revenue went from $1.02B in 2008 to $4.3B in 2025.
Diluted earnings per share
Diluted EPS went from $0.94 in 2008 to $13.08 in 2025. Ten-year growth: 20.4% a year.
Shares outstanding
13.5% fewer shares in 2025 than in 2015 (93.6M → 81M): buybacks outweighed new shares.
Operating cash flow, capex and free cash flow
Free cash flow (operating cash flow minus capital expenditure) was $1.06B in 2025, 24.6% of revenue.
The chart data could not be loaded. The table below has the same figures.
Year by year
| Fiscal year | Revenue | Net income | Net margin | Diluted EPS | Shares | Operating cash flow | Capex | Free cash flow |
|---|---|---|---|---|---|---|---|---|
| 2025 | $4.3B | $1.06B | 24.6% | $13.08 | 81M | $1.18B | $125M | $1.06B |
| 2024 | $3.9B | $888M | 22.8% | $10.67 | 83.2M | $929M | $121M | $808M |
| 2023 | $3.66B | $845M | 23.1% | $10.06 | 84M | $907M | $134M | $773M |
| 2022 | $3.37B | $679M | 20.2% | $8.03 | 84.6M | $543M | $149M | $394M |
| 2021 | $3.22B | $745M | 23.2% | $8.60 | 86.6M | $756M | $120M | $636M |
| 2020 | $2.71B | $582M | 21.5% | $6.71 | 86.7M | $648M | $107M | $541M |
| 2019 | $2.41B | $428M | 17.8% | $4.89 | 87.5M | $459M | $155M | $304M |
| 2018 | $2.21B | $377M | 17.0% | $4.26 | 88.5M | $400M | $116M | $284M |
| 2017 | $1.97B | $263M | 13.4% | $2.94 | 89.6M | $373M | $74.4M | $299M |
| 2016 | $1.78B | $222M | 12.5% | $2.44 | 90.9M | $339M | $64.8M | $274M |
| 2015 | $1.6B | $192M | 12.0% | $2.05 | 93.6M | $222M | $82.9M | $139M |
| 2014 | $1.49B | $182M | 12.2% | $1.79 | 102M | $236M | $60.5M | $175M |
| 2013 | $1.38B | $188M | 13.6% | $1.74 | 108M | $246M | $77.6M | $168M |
| 2012 | $1.29B | $178M | 13.8% | $1.58 | 112M | $222M | $57.6M | $165M |
| 2011 | $1.22B | $162M | 13.3% | $1.39 | 116M | $218M | $49.7M | $168M |
| 2010 | $1.1B | $141M | 12.8% | $1.19 | 119M | $179M | $38.9M | $140M |
| 2009 | $1.03B | $122M | 11.8% | $1.00 | 121M | $175M | $50.7M | $124M |
| 2008 | $1.02B | $116M | 11.3% | $0.94 | 124M | $143M | $90M | $53.3M |
Fiscal years, labelled by the year in which they end. US dollars; per-share figures and share counts adjusted for splits. —: not in the data.
Stock splits
Found in the filings; per-share figures and share counts on this page are on today’s share basis.
- 2-for-1 split · first reflected in a filing of July 30, 2015
About these figures
- No dividends per share in the filings data. Usually that means no dividend, but some companies report theirs in a form the data do not capture.
- Older years are as filed at the time and may predate later restatements, mergers or spin-offs. How the figures are made.
Other Health Care Equipment companies
Source: SEC EDGAR (company filings), data as of November 8, 2026. Sectors, sub-industries, headquarters and index dates: Wikipedia, CC BY-SA 4.0.